We show that ceramide synthase 2 (CERS2) undergoes a unique AS event where Exon 8 is skipped in Luminal B subtype patients, and validate the differential expression of CERS2 isoforms in Luminal B representative cancer cells and tumor tissues. Here, CERS2 is linked to neoplasm.